Well, confirmation has finally come about that the DEA will reclassify #cannabis to Schedule III, which brings about the alleviation of 280e. Congrats to all $MSOS and cannabis equity holders for staying the course. Hopefully your just reward is due.
https://t.co/J3hSDhKhWO
Cowen sell side Managing Director and cannabis analyst, Vivien Azer, is moving on. She announced these intentions tonight on LinkedIn.
Of note: a final pontification on U.S. cannabis, which she deems "is still set to be the most disruptive consumer trend of my lifetime." $MSOS